The same single nucleotide polymorphisms (SNPs) linked to an increased risk of Alzheimer’s disease are associated with cognitive decline in patients with Parkinson’s disease, according to new study findings presented at the AAN conference.
The same single nucleotide polymorphisms (SNPs) linked to an increased risk of Alzheimer’s disease are associated with cognitive decline in patients with Parkinson’s disease, according to new study findings presented at the AAN conference.